Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The PRCRP was initiated in 2009 to provide support for cancer research of exceptional scientific merit not addressed by the breast cancer, prostate cancer, lung cancer, and ovarian cancer research programs executed and managed by the Office of the Congressionally Directed Medical Research Programs (CDMRP).
The goal of the PRCRP is to improve mission readiness and quality of life by decreasing the burden of cancer on Service members, their families, and the American public. The PRCRP is charged by Congress with the mission to investigate cancer risks and knowledge gaps that may be relevant to active duty Service members, their families, other military beneficiaries, and the American public.
Característiques principals
To be considered for funding, applications for the PRCRP Career Development Award must address at least one of the Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), kidney, melanoma or ovarian cancer will not be accepted. The FY19 PRCRP Topic Areas are listed below.
  • Bladder cancer
  • Blood cancers
  • Brain cancer
  • Cancer in children, adolescents, and young adults1
  • Colorectal cancer
  • Immunotherapy2
  • Listeria vaccine for cancer
  • Liver cancer
  • Lymphoma
  • Mesothelioma
  • Neuroblastoma
  • Pancreatic cancer
  • Pediatric brain tumors
  • Rare cancers3
  • Stomach cancer
    New for FY19: Studies involving melanoma (including rare subtypes of melanoma) should apply to the new FY19 Melanoma Research Program. Studies involving other skin cancers will be accepted by the PRCRP under an appropriate FY19 PRCRP Topic Area (i.e., immunotherapy)

    There are four award mechanisms:
  • Impact awards: Supports Independent investigators at or above the level of Assistant Professor (or equivalent), to conduct hypothesis-driven, high-impact research.
  • Horizon Award: Supports junior-level scientists in conducting impactful research with the mentorship of an independent cancer researcher (i.e., Mentor)
  • Career Development Awards: Supports independent, early-career investigators to conduct impactful research with the mentorship of an experienced cancer researcher.
  • Idea Award with Special Focus: Supports Independent investigator with a faculty-level appointment (or equivalent), to conduct innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are relevant to Service members, Veterans, military beneficiaries, and the American public..
  • Translational Team Science Award: Supports a team of 2-3 PIs, to conduct hypothesis-driven translational studies that are associated with an ongoing or completed clinical trial and are focused on research for the next-phase clinical research.
    		•
    Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: cbarnwell@imim.es Ext.: 1670
    Marta López: mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    http://cdmrp.army.mil/funding/prcrp
    Dotació
  • Impact award: $1,000,000
  • Horizon Award: $150,000
  • Career Development Award: $360,000
  • Idea Award with Special Focus: $400,000
  • Translational Team Science Award: $1,500,000
    • Durada
  • Impact award: 3 years
  • Horizon Award: 2 years
  • Career Development Award: 3 years
  • Idea Award with Special Focus: 2 years
  • Translational Team Science Award: 4 years
    • AVÍS IMPORTANT
    Pre-Application (Preproposal) deadline:
  • Impact award: 22 May 2019
  • Horizon award: 21 August 2019
  • Career Development Award: 21 August 2019
  • Idea Award with Special Focus: 22 May 2019
  • Translational Team Science Award: 22 May 2019
    Full application deadline: September 11, 2019

    • Arxius

    Arxiu
    FY19-PRCRP-IASF.pdf
    FY19-PRCRP-CDA.pdf
    FY19-PRCRP-HA.pdf
    FY19-PRCRP-TTSA.pdf
    FY19-PRCRP-IPA.pdf
    FY19-PRCRP-GAI.pdf
    19prcrpreftable.pdf